StockDrifts LogoStockDrifts

RECURSION PHARMACEUTICALS, INC. · RXRX · 4 · Filed

Director Blake Borgeson sells $100,200 of stock

RXRX
4
Insider trades
Insider sell

Source: SEC EDGAR, accession 0001601830-26-000103

What did RECURSION PHARMACEUTICALS, INC. announce?

Director Blake Borgeson sold 30,000 shares of common stock for a total of $100,200.

Key details

  • Blake Borgeson, a Director, sold 30,000 shares.
  • The total value of the transaction was $100,200.00.
  • The sale was executed under a 10b5-1 trading plan.

Why it matters

This 4 reports an insider transaction at RECURSION PHARMACEUTICALS, INC.. The likely share-price reaction reads as negative.

Bearish

More from RECURSION PHARMACEUTICALS, INC.

All RECURSION PHARMACEUTICALS, INC. SEC filings →

View on SEC.gov